The lead on the debenture sale slaps their own client.  

Guts 2023 from 0.07 EPS to 0.00

Guts 2023 ITS EBITDA to 23M.  Below Cannacord's last estimate of $24M.  But kisses the same cheek and getting  to a 2.75 target by giving a 12X multiple on ITS earnings when industry is at 8X.

To get $2.75 need to to turk a 6M qtrly loss and turn to a 6M gain.... and see multiple expand by 50%.  Fantasy land!